Literature DB >> 12374457

The endocrine system in diabetes mellitus.

Hisham Alrefai1, Hisham Allababidi, Shiri Levy, Joseph Levy.   

Abstract

The pathophysiology of diabetes mellitus is complex and not fully understood. However, it emerges as an abnormal metabolic condition associated with a systemic damage to the vascular bed. Cumulative evidence also reveals that the endocrine system is not intact in patients with diabetes mellitus. It is not clear whether the changes observed in the endocrine system represent a primary defect or reflect the effects of the impaired insulin action and abnormal carbohydrate and lipid metabolism on the hormonal milieu. Review of the literature reveals that the function of the entire endocrine system including the functions of hormones from the hypothalamus, pituitary, adrenal, thyroid, parathyroid, the vitamin D system, the gonads, and the endocrine function of the adipose tissue, is impaired. Good metabolic control and insulin treatment may reverse some of these abnormalities. It remains unanswered as to what extent these changes in the endocrine system contribute to the vascular pathologies observed in individuals affected by diabetes mellitus and whether part of the abnormalities observed in the endocrine system reflect a basic cellular defect in the diabetic syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 12374457     DOI: 10.1385/ENDO:18:2:105

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  306 in total

1.  Effects of supplementation of the maturation media with insulin on in vitro maturation and in vitro fertilization of bovine oocytes.

Authors:  M Matsui; Y Takahashi; M Hishinuma; H Kanagawa
Journal:  Jpn J Vet Res       Date:  1995-12       Impact factor: 0.649

2.  Comparison of fasting plasma leptin concentrations in healthy subjects with high and low plasma insulin.

Authors:  I Zavaroni; P Gasparini; A I Barilli; P Massironi; C Campanini; M Carantoni; R Delsignore; G M Reaven
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

3.  An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls.

Authors:  Y Okamoto; Y Arita; M Nishida; M Muraguchi; N Ouchi; M Takahashi; T Igura; Y Inui; S Kihara; T Nakamura; S Yamashita; J Miyagawa; T Funahashi; Y Matsuzawa
Journal:  Horm Metab Res       Date:  2000-02       Impact factor: 2.936

4.  Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria.

Authors:  A Verrotti; F Basciani; F Carle; G Morgese; F Chiarelli
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

5.  Influence of residual C-peptide secretion on nocturnal serum TSH peak in well-controlled diabetic patients.

Authors:  V Coiro; R Volpi; C Marchesi; L Capretti; G Speroni; G Caffarri; P Chiodera
Journal:  Clin Endocrinol (Oxf)       Date:  1997-09       Impact factor: 3.478

6.  Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.

Authors:  G B Phillips; C H Tuck; T Y Jing; B Boden-Albala; I F Lin; N Dahodwala; R L Sacco
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

7.  Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy.

Authors:  R D Hoeldtke; G Boden; C R Shuman; O E Owen
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

8.  Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.

Authors:  M W Schwartz; A M Strack; M F Dallman
Journal:  Regul Pept       Date:  1997-10-31

9.  Functional and morphological changes in mediobasal hypothalamus of streptozocin-induced diabetic rats. In vitro study of LHRH release.

Authors:  G E Bestetti; C E Boujon; M J Reymond; G L Rossi
Journal:  Diabetes       Date:  1989-04       Impact factor: 9.461

10.  Pituitary thyrotroph function and thyroid hormones in longstanding type-II diabetes mellitus before and after insulin treatment.

Authors:  C Schnack; G Schernthaner
Journal:  Exp Clin Endocrinol       Date:  1987-09
View more
  6 in total

1.  Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus.

Authors:  Rebecca L Erickson; Caroline A Browne; Irwin Lucki
Journal:  Physiol Behav       Date:  2017-01-12

Review 2.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

3.  Oxytocin and psychological factors affecting type 2 diabetes mellitus.

Authors:  K Kontoangelos; A E Raptis; C C Papageorgiou; P C Tsiotra; G N Papadimitriou; A D Rabavilas; G Dimitriadis; S A Raptis
Journal:  Exp Diabetes Res       Date:  2012-09-10

4.  Continuous glucose monitoring during pregnancy in healthy mice.

Authors:  Caroline Wuyts; Caroline Simoens; Silvia Pinto; Koenraad Philippaert; Rudi Vennekens
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

5.  Comprehensive Network Analysis Reveals the Targets and Potential Multitarget Drugs of Type 2 Diabetes Mellitus.

Authors:  Wan Zhou; Qiang Liu; Wei Wang; Xiao-Jing Yuan; Chun-Chun Xiao; Shan-Dong Ye
Journal:  Oxid Med Cell Longev       Date:  2022-07-28       Impact factor: 7.310

6.  Comparative study on the effects of type 1 and type 2 diabetes on structural changes and hormonal output of the adrenal cortex in male Wistar rats.

Authors:  Zohreh Elahi-Moghaddam; Morteza Behnam-Rassouli; Naser Mahdavi-Shahri; Roya Hajinejad-Boshroue; Elaheh Khajouee
Journal:  J Diabetes Metab Disord       Date:  2013-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.